NHS England issues £755m tender including monoclonal antibodies

NHS England has issued a £755m procurement tender which includes the supply of monoclonal antibodies, with delivery to commence in March 2021.

The tender recognises the growing importance of monoclonal antibodies and aims to establish a pharmaceutical medicines framework for this group of medicines.

There are four lots in the tender, two for NHS Midlands and East, one for pan-London regions and one for South of England. The lots cover the supply of a number of pharmaceutical products, including annual tranche, cytokine modulators, other monoclonal antibodies, interleukin inhibitors, JAK inhibitors and medicines for migraine and asthma.

The one year framework for NHS England and East includes an optional extension of up to 12 months.

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.